A functional and structural basis for TCR cross-reactivity in multiple sclerosis.

A functional and structural basis for TCR cross-reactivity in multiple sclerosis.

The multiple sclerosis (MS)-associated HLA major histocompatibility complex (MHC) class II alleles DRB1*1501, DRB5*0101 and DQB1*0602 are in strong linkage disequilibrium, making it difficult to determine which is the principal MS risk gene. Here we show that together the DRB1 and DRB5 loci may infl...

Bibliografske podrobnosti
Main Authors:	Lang, H, Jacobsen, H, Ikemizu, S, Andersson, C, Harlos, K, Madsen, L, Hjorth, P, Sondergaard, L, Svejgaard, A, Wucherpfennig, K, Stuart, D, Bell, J, Jones, E, Fugger, L
Format:	Journal article
Jezik:	English
Izdano:	2002

Podobne knjige/članki

TCR transgenic mice that shed light on immune and environmental regulators in multiple sclerosis.
od: Attfield, K, et al.
Izdano: (2013)

TCR beta polymorphisms and multiple sclerosis.
od: Dyment, D, et al.
Izdano: (2004)

T cell cross-reactivity and conformational changes during TCR engagement.
od: Lee, J, et al.
Izdano: (2004)

A molecule basis for the HLA association in rheumatoid arthritis.
od: Andersson, E, et al.
Izdano: (2000)

Evidence for genetic basis of multiple sclerosis
od: Sadovnick, A, et al.
Izdano: (1996)

Functional epistasis on a common MHC haplotype associated with multiple sclerosis.
od: Gregersen, J, et al.
Izdano: (2006)

From genes to function: the next challenge to understanding multiple sclerosis
od: Fugger, L, et al.
Izdano: (2009)

From genes to function: the next challenge to understanding multiple sclerosis.
od: Fugger, L, et al.
Izdano: (2009)

Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
od: Krogsgaard, M, et al.
Izdano: (2000)

A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.
od: Dendrou, C, et al.
Izdano: (2013)

Immunomodulation in multiple sclerosis: promises and pitfalls
od: Dendrou, C, et al.
Izdano: (2017)

T cells and microglia as drivers of multiple sclerosis pathology.
od: Friese, M, et al.
Izdano: (2007)

T cells and microglia as drivers of multiple sclerosis pathology
od: Friese, M, et al.
Izdano: (2007)

Pathogenic CD8(+) T cells in multiple sclerosis.
od: Friese, M, et al.
Izdano: (2009)

Linkage analysis of a candidate region in Scandinavian sib pairs with multiple sclerosis reveals linkage to chromosome 17q.
od: Larsen, F, et al.
Izdano: (2000)

Multiple sclerosis: MHC associations and therapeutic implications.
od: Holmes, S, et al.
Izdano: (2005)

A GENETIC-BASIS FOR FAMILIAL AGGREGATION IN MULTIPLE-SCLEROSIS
od: Ebers, G, et al.
Izdano: (1995)

The immunology of multiple sclerosis
od: Attfield, KE, et al.
Izdano: (2022)

The value of animal models for drug development in multiple sclerosis
od: Friese, M, et al.
Izdano: (2006)

The value of animal models for drug development in multiple sclerosis.
od: Friese, M, et al.
Izdano: (2006)

Misfiring in multiple sclerosis: cerebellar channelopathy, a potential novel target?
od: Craner, M, et al.
Izdano: (2012)

Interleukin-17 expression in multiple sclerosis
od: Tzartos, J, et al.
Izdano: (2006)

Autoreactive CD8+ T cells in multiple sclerosis: A new target for therapy?
od: Friese, M, et al.
Izdano: (2005)

Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
od: Friese, M, et al.
Izdano: (2005)

Interrogating the recognition landscape of a conserved HIV-specific TCR reveals distinct bacterial peptide cross-reactivity
od: Mendoza, Juan L, et al.
Izdano: (2021)

Association of MHC and rheumatoid arthritis. HLA-DR4 and rheumatoid arthritis: studies in mice and men.
od: Fugger, L, et al.
Izdano: (2000)

Therapies for multiple sclerosis: translational achievements and outstanding needs.
od: Haghikia, A, et al.
Izdano: (2013)

Bridging the gap from genetic association to functional understanding: the next generation of mouse models of multiple sclerosis.
od: Attfield, K, et al.
Izdano: (2012)

TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling.
od: Abrahamsen, H, et al.
Izdano: (2004)

Dissection of the multiple sclerosis associated DR2 haplotype.
od: Etzensperger, R, et al.
Izdano: (2008)

Effects of N-butyldeoxynojirimycin and the Lec3.2.8.1 mutant phenotype on N-glycan processing in Chinese hamster ovary cells: application to glycoprotein crystallization.
od: Butters, T, et al.
Izdano: (1999)

Factors affecting TCR-repertoire diversity.
od: Wedderburn, L, et al.
Izdano: (1994)

Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient
od: Wurm, H, et al.
Izdano: (2020)

On the Control of TCR Phosphorylation.
od: Fernandes, R, et al.
Izdano: (2012)

The TCR triggering puzzle.
od: Van Der Merwe, P
Izdano: (2001)

Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group.
od: Sadovnick, A, et al.
Izdano: (1996)

Organisation of, and ligand-independent signalling by the TCR, with a special emphasis on the pre-TCR
od: Huang, E
Izdano: (2017)

Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy.
od: Siebold, C, et al.
Izdano: (2004)

Neuromyelitis optica spectrum disorder and multiple sclerosis can be distinguished on the basis of MRI brain lesion characteristics
od: Matthews, L, et al.
Izdano: (2012)

TCR signaling: the barrier within.
od: Dustin, M, et al.
Izdano: (2014)